COVID-19 case management: The policy model in Morocco context

Abstract Background: Based on the updated scientific evidence around SARS-CoV-2 diagnostic, health policymakers had to consider that many decisions could enhance or limit the success of the overall COVID-19 control strategy. The purpose of this study is to share alternative COVID-19 case management based on the updated international knowledge. Methods: This study presents the main information about COVID-19 case management in Morocco from March to October 2020. The NVivo qualitative model content analysis was used to compare and prioritize health decisions with updated scientific evidence. Results: The lack of molecular diagnostic accuracy using the interpretation of cycles quantification values, was targeted only by allowing all private laboratories to do RT qPCR. However, there is an urgent need for standardisation with accurate molecular SARS-CoV-2 thermocyclers and kits that notify systematic cycles quantification and do more tests per days to control the spread effectively. A predictive tree of the cycle's range is presented following three steps: 1) the initial clinical definition, 2) the molecular confirmation, 3) and the diagnostic follows up results of the RT qPCR up to 28 days after the onset. At the same time, the seasonal vaccination against influenza and pneumonia could help to reduce COVID-19 deaths. Conclusions: Until an available SARS-CoV-2 specific vaccine and/or curative effective treatment, updated control strategy in Morocco and similar context countries require to target population living in highly COVID-19 epidemic cities or areas by mass testing with the right interpretation of PCR values changes, associated to seasonal vaccination to foster the immunity.

without any restrictions for who can be tested or not. Thus, everyone who can pay 60 to 70 $US as unitary molecular test cost, could get within a theoretical 48 hours a confirmation result.
Finally, the decision n°80 on October 15 th , 2020 promoted the start of media campaign around Influenza vaccination for old persons more than 64 years old and children under 5yo, by invitation to take the vaccine from the private sector at 12 $US per unit and defined an objective to get a 60% of inductive immunity in a specific targeted population that the MoH will vaccine free of charge (all health professionals and health students in the public sector, all pregnant women at the last six months and all hemodialyzed persons followed in the public sector).
The study aim is to share alternative COVID-19 case management based on the available scientific evidence to decrease deaths within a short time.

Methods
This article methodology describes the use of qualitative content analysis to analyse official documents published about the COVID-19 case management in Morocco. The formal guideline and checklist of such research design are under development in EQUATOR Network database, as a new structure for quality improvement reports. The main steps cited are the brief description of context, key measures for improvement from one side (provider or government), what would constitute improvement from a different side (expert practices, patients or scientific evidence), analysis and interpretation, to reach a proposition of a strategy for change [3].
Then, the analysis method adopted is well known in social sciences and newly more used for health policy topics. We followed mainly the method described in Hall&Steiner 2020 article[4].
This model was associated with the EQUATOR model, and multiple models suggesting the . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint implementation of a modified strategy after decision analysis [5]. Therefore, the combined final The coding tree was divided into the COVID-19 primary outcomes (deaths or recovering states), and the keywords included in the MoH strategic decisions and hypothesis.
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint

Results
Twenty articles from the review were selected as presenting valuable evidence that confronts the policy themes. This section summarises the main themes gathered from the coding tree:

I. COVID-19 parameters in Morocco and the lethality assessment
Morocco, with its 36 Million citizens, noticed the first imported case, on March 2 nd , 2020. Then, the spread of COVID-19 cases in all the twelve administrative Moroccan regions raised many individual and collective cases. The metropolitans four cities (Casablanca the biggest one, Marrakech, Tangier, and Fez) had almost 70% of the cases. Unfortunately, a considerable increase is reported during August with around 20 to 40 deaths per day (e.g., On August 31 there was 62590 confirmed cumulative cases and 1141 cumulative deaths). However, during September, only Casablanca and Marrakech sustained a high level of confirmed cases, but the overall deaths remained stable between 40 ± 07 per day (e.g., On September 30 there was 102715 confirmed cumulative cases and 2194 cumulative deaths; unfortunately on October 31 the confirmed cumulative cases were 219084 with 3695 cumulative deaths).
The net lethality ratio is the total number of deaths due to COVID-19 divided by the overall confirmed COVID-19 cases. This ratio moves slowly around 1,7% and does not add any useful analysis (Figure2). Thus, COVID-19 lethality could be presented with standardisation to a minimal number of the general population. (The days' tests do no go further than 23000 tests per day for technical reasons, even by inviting all private laboratories to do SARS-CoV2 tests. The control strategy does not target mass enrolment of all suspected COVID-19 cases). As shown in Figure3, the standardised death ratio is expected to increase from less than ten deaths . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint per one Million habitants to be more than 220 deaths per one Million citizens by the end of the year with an estimation around 7700 lives lost.
In other studies, the mortality rate of COVID-19 is commonly calculated comparing the numbers of patients who were discharged well recovered versus those who died by a timing endpoint (e.g. during the 30 past days) [7].

II. Point of care (PoC) serology tests and vaccination as preventives measures
The IgG serodiagnosis rapid tests that could be used are not considered as the gold standard test due to their not satisfactory accuracy and are mostly used to show the seroconversion and the previous exposure to the virus after at least ten days from the onset of the symptoms. In Morocco, the rapid test trademark used showed in foreign studies a better sensitivity after 14 days from the onset of symptoms and raised some concerns about its usefulness for COVID-19 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint PoC allowing detection of both viruses in the same test, unfortunately, the accuracy assessment would not be available before the end of the winter in the Northern hemisphere.
Moreover, for this year, the anti-flu vaccine is expected to be a quadrivalent influenza vaccine containing one strain from each B lineage in addition to H1N1 and H3N2 strains [18]. The intention to be vaccinated by seasonal influenzas increase with the COVID-19 risk perception and increase of age in the UK [19]. Then, the yearly quantities should be increased. Another study from Brazil explains the presence of an association between the inactivated trivalent influenza vaccine and lower mortality among Covid-19 patients; such study results are available due to the seasonal vaccination in the southern hemisphere done in past April and May in concomitance with the COVID-19 emergence [20]. However, the results could be taken with more caution due to the possible presence of a herd immunity effect that allowed less mortality as reported in another previous study from a small town located in Brazil [21].  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint

III. The RT-qPCR accuracy
For some scientists and health laboratory workers, the big challenge is that the PCR is not appropriate to detect virus infections, but it still used due to its ability to replicate DNA sequences by reverse transcriptase method. However, the amount of DNA obtained with the same RNA material can vary widely. As consequences, if the specificity of this technic is almost 95 %, its sensitivity is considered at least around 70% [27] More, RNA extraction step represents a major bottleneck due to reagents shortage, cost, polling technic and time-consuming procedures [2,28]. Some clinical and testing errors (ineffective symptom screening, sampling errors, sample contamination,.) and analytical testing errors In Morocco, the case management strategy was initially based on the PCR' results to confirm the COVID-19' positivity and the negative control results to declare recovering. However, the only information available at the operational level was the qualitative binary appreciation of this test (Positive, Or Negative). Indeed, some commercialised SARS-CoV-2 kits for RT-qPCR (the cheapest ones) are only qualitative, contrary to the fact that the "q" in "qPCR" stands for "quantitative". However, some manufacturers declare possible to use additional specific software's to define the viral load by indirect calculations [31]. While, good laboratory practices . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint emphasise that RT-qPCR should provide the viral load indirect and individual quantification, to allow to match with the required minimal information needed for results declaration [33].

IV. The role of cycles quantification values
One of the public health benefices to investigate the cycles quantification values (Cq) (anciently named cycle threshold) of all affected persons, is to control the overall severity of the different periods of epidemy that happen in the country. As an example, Italy described the trend of the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint

V. Household stay and asymptomatic cases management
The asymptomatic cases could be an essential source of contagion and need to be controlled biologically via virus nucleic acid testing [42]. Even if, the presence of RNA in RT-qPCR does not necessarily correlate with infectivity or transmission capacity, or at least is not yet easy to prove it scientifically [43]. However, studies published before July 2020 reported that the viral load detected was similar in both asymptomatic and the symptomatic patients, which prove the transmission potential of asymptomatic patients and minimally symptomatic ones [35, 42,44], Since August 01 st , in Morocco, due to more severe cases needing intensive emergency cares and hospital beds, the asymptomatic patients or those with few and minim symptoms are invited to take the adjuvant medication and stay in their homes (Figure1a). While, the evidence from China and USA show that households sites are the most favourable areas to spread the disease between 33% and 55% of the parents, partners, spouses and children were affected by their positive in-home person living with them. The odds ratio of the infectivity increases by seven to fifteen times if the residents in the household have some associated morbidities such diabetes or immunocompromised health conditions [45,46]. Ignorance, small habitations, less favourable social conditions, and inappropriate houses living conditions are the common risk factors for more inhouse infectivity.

VI. The duration of isolation and infectivity risk
Substantial viral loads can be detected around day five of infection and decrease gradually based on the characteristics of the disease or the effective antiviral treatments taken [35,47]. In contrast, the virus load and transmission events start earlier two to three days before symptom onset [48]. While at the beginning of the pandemic, some studies 14 days of isolation after . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint diagnosis stated to be sufficient to get negativity [49]. In contrast from Wuhan in China, the onset of the symptoms was linked to the percentage of positive results. This positivity declined from 100% in week one, to 66% in week three, and 32% in week four, to 5 and 0% in weeks five and six [36]. Then, the accuracy is correlated to the duration from the symptoms onsets, and the day 24 th is the mean date to get negativity [36]. Another study from Italy reported that the timeline of Cq value would be negative between 21 and 28 days [50]. Then, for both patients and health workers suggest a longer time of self or supervised isolation [51].
In contrast, the MoH assume two unchangeable hypotheses that become useless: the person is no longer transmitting virus ten days after symptom resolution and COVID-19 patient's loss their infectivity after seven days under treatment. Consequently, the isolation should be increased from 14 to 28 days and balanced with the following parameters (the asymptomatic state, the overall duration from the beginning of the symptoms, the younger vs older, the time change of the cycles quantification). Moreover, nosocomial infections are sustained by the high level of contamination of air and surface by SARS-CoV-2 in hospital rooms. One study from Singapore hospitals reported more than 56% of environmental hospital rooms contamination and more than 66% of hospital . CC-BY 4.0 International license It is made available under a perpetuity.

VII. Hospital environment and laboratory safety matters
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint surface contamination [53]. In contrast, the Cq value of contaminated rooms and noncontaminated rooms were equal to 25 and 33, respectively [53].
False positives results occur in a laboratory if reagents become contaminated, which is a significant concern about the testing volume during a pandemic. Indeed, the occurrence of contaminations of commercial primers of SARS-CoV-2 affects diagnostic specificity. Thus, the need to pre-test each batch of reagents before using in routine is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint

Discussion
Well-designed COVID-19 case management could be achievable by understanding some decisions should not be in opposition to scientific evidence nor by limiting the use of molecular test and nor by introducing PoC as the first diagnostic for recent suspected cases or contacts leading to false-negative non treated patients, and nor by starting treating in-home asymptomatic cases with a notification of recovering based only on clinical criteria (e.g. from is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint lethality ratio in Morocco, and the mandatory BCG vaccination is not proved. Indeed, a retrospective cohort study found that BCG vaccination in childhood has no protective effects against COVID-19 in adulthood [61]. Another study from Sweden concludes to the absence of any protective effect against the COVID-19 in BCG vaccinated persons during infancy [62].
Fourthly, the effectiveness and time to get an adequate worldwide immunisation by a specific future COVID-19 vaccination, and it could be mandatory for all citizens, or only international travels remain questionable [63]. Finally, the MoH could mess a better cost-effective way to control this virus by taking for this winter season the mandatory vaccination against influenza that will be beneficial to limit indirectly COVID-19 deaths in the targeted population. That recommendation was not formulated, due to the end of the yearly expressed anti-flu vaccine needs and the official declaration to acquire the anti-COVID-19 vaccine as the main priority.

Conclusions
Our work meets the same conclusion of other international researchers[36,57], RT-qPCR reported as a binary positive or negative result removes useful information that could inform clinical decision making or at least enhance it. This study proposes new case management to address the uncontrolled situation that could be adapted to local contexts and used by many other countries. On one side, massive seasonal vaccination to reach induced collective immunity level for all ordinary targeted population including the COVID-19 new suspected patients aged > 6 months, and on the other side, implement a mass molecular diagnostic control of COVID-19 as primary diagnostic intention. In comparison, local manufacturing of accurate PCR kits could be a cost-effective scenario to reach all diagnostic needs within the suspected population and its neighbourhood. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint

Availability of data and materials
The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate
This paper does not contain any studies done by the authors involving human participants. It is based on a review of the literature and public statistical available data updated each day by the Moroccan Ministry of Health and available by the website link: http://www.covidmaroc.ma

Competing interests
The author declares that he has no conflict of interest and no financial support.

Source of Financing
No funding source supported the study     is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

List of Figures included in the paper
The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint Tables and Figure available Table 2: Phase 3-COVID-19 case management of Asymptomatic young person (Less than 45 years old) without known chronic comorbidities, with regard of RT-qPCR (diagnostic result vs control result) based on the interpretation of the Cq range progress. Table 3: Phase 3-COVID-19 case management of Symptomatic immunocompetent young person or asymptomatic young person with comorbidities, with regard of RT-qPCR (diagnostic result vs control result) based on the interpretation of the Cq range progress. Table 4: Phase 3-COVID-19 case management of Aged person more than 65 years with any health state or Symptomatic Young person with comorbidities, with regard of RT-qPCR (diagnostic result vs control result) based on the interpretation of the Cq range progress. Table 5 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

Additional file
The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint ✓ The wright pillar, describe the themes linked to the safety matter in hospitals due to uncontrolled nosocomial infections, the best time to use PoC rapid diagnostic tests, the added value and risk of increased infectivity if the decision of isolation in household and duration of isolation are not respected or risky shortened with the role of seasonal vaccination as a preventive measure.
As consequences, the overall estimation of direct deaths due to COVID-19 is partly due to the management strategy pitfalls or priorities (associated to indirect deaths for patients non-COVID-19 who are facing death by unmet health needs) and are partly due to misconduct collective behaviours by increasing unnecessary risk of public infectivity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

Figure2: Active COVID-19 patients and issued deaths in Morocco between March and October 2020
NB: The linear graph of the net lethality ratio is showing a sustainable decrease over time, which is confusing, while the standardised lethality ratio linear graph shows an increased linear tendency.

Clinical interpretation of the expected percentage of the viral load:
If the viral load percentage is estimated clinically (High) between 100% and 89%, One RT-qPCR will be done from sputum, pharynx, Saliva, or nasopharynx specimen. If negative, another immediate RT-qPCR will be done from nasopharynx specimen If the viral load percentage is estimated (Medium) at 66%, One RT-qPCR will be done from a nasopharynx specimen. If negative, another immediate RT-qPCR will be done from nasopharynx specimen If the viral load percentage is estimated clinically (low) between 32% and 05% just one RT-qPCR from the Nasopharynx should be done. If negative, surveillance for one week then IgM/IgG PoC rapid test . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 10, 2020. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

Figure4-Phase 2-Molecular confirmation and diagnostic control decision tree
The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.07.20227603 doi: medRxiv preprint 31 Additional file Table2-Phase 3-COVID19 case management of Asymptomatic young person (Less than 45 years old) without known chronic comorbidities, with regard of RT-qPCR (diagnostic result vs control result) based on the interpretation of the Cq range progress: Diagnostic process based on the Cq range of the PCR diagnostic result and the PCR control result (one week after) Diagnostic interpretation based on the cycle quantification (or threshold cycle)

NB:
The notification should be systematic for all positive results by reporting the Cq values. (Consecutive two negative tests at the control time repeated twice after 14 and 28 days or after 20 and 28 days could be justified in the current context to declare recovery if both negatives)